newsfilter
← Latest News
Business Wire·

Pfizer Showcases Clinical Advancements Across Infectious Diseases at IDWeek 2026

Data from 57 abstracts will highlight Pfizer’s scientific progress targeting infectious diseases, including pneumococcal disease and RSV Pfizer Inc. (NYSE:PFE) will present data from more than 50 company-sponsored,